2-(4-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)cyclohexyl)acetic acid

Catalog No.: 
ACSURN609
CAS No.: 
1023821-72-8
Molecular Formula: 
C23H25NO4
Molecular Weight: 
379.46
2-(4-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)cyclohexyl)acetic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$70.00InquiryInquiry
100mg95%$98.00InquiryInquiry
250mg95%$133.00InquiryInquiry
1g95%$330.00InquiryInquiry
5g95%$925.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(4-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)cyclohexyl)acetic acid
IUPAC Name2-(4-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)cyclohexyl)acetic acid
MDL No.MFCD03453265
Molecular FormulaC23H25NO4
Molecular Weight379.46
SMILESO=C(O)CC1CCC(NC(OCC2C3=C(C4=C2C=CC=C4)C=CC=C3)=O)CC1
InChI KeyOAZYEKKFVGYBHJ-UHFFFAOYSA-N
Synonym2-[4-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)cyclohexyl]acetic acid;Cyclohexaneacetic acid, 4-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-;2-[4-(Fmoc-amino)cyclohexyl]acetic Acid;4-(Fmoc-amino)cyclohexaneacetic acid
CAS No.1023821-72-8

Synthetic Route by SureRoute

1. ACSURN609 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFCJQ560 route compound structure diagram
    ACFCJQ5601197-54-2In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACSURN609 route product structure diagram
    ACSURN6091023821-72-8
Inquiry

2. ACSURN609 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSURN609 route product structure diagram
    ACSURN6091023821-72-8
Inquiry

3. ACSURN609 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSURN609 route product structure diagram
    ACSURN6091023821-72-8
Inquiry

Comments (0)